Matches in Wikidata for { <http://www.wikidata.org/entity/Q92804937> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q92804937 description "article scientifique publié en 2019" @default.
- Q92804937 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92804937 description "scientific article published on 24 December 2019" @default.
- Q92804937 description "wetenschappelijk artikel" @default.
- Q92804937 description "наукова стаття, опублікована 24 грудня 2019" @default.
- Q92804937 name "UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma" @default.
- Q92804937 name "UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma" @default.
- Q92804937 type Item @default.
- Q92804937 label "UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma" @default.
- Q92804937 label "UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma" @default.
- Q92804937 prefLabel "UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma" @default.
- Q92804937 prefLabel "UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma" @default.
- Q92804937 P1433 Q92804937-09532D42-B9A2-433B-BBC0-9A1CBAF5A9A2 @default.
- Q92804937 P1476 Q92804937-FDE7CBD9-E1C7-4542-8B6A-3073450862C6 @default.
- Q92804937 P2093 Q92804937-0CA83CD6-A83E-4CB8-A79D-8EF81CBDE342 @default.
- Q92804937 P2093 Q92804937-1B63BB6F-17AF-4604-BF7B-9C7BBC79FC53 @default.
- Q92804937 P2093 Q92804937-1BEECC80-994C-4F64-ADBD-927F655505A2 @default.
- Q92804937 P2093 Q92804937-F89EDDC0-DF1B-4AE6-B202-2791FDF50D9E @default.
- Q92804937 P304 Q92804937-CB24CA18-B7B0-4255-BC1B-254035871F9A @default.
- Q92804937 P31 Q92804937-AC73DD5A-5CC9-4441-BDFB-D7BD95CDA16C @default.
- Q92804937 P356 Q92804937-948A0694-C881-4A2F-A445-E0ED2B0EB8E5 @default.
- Q92804937 P478 Q92804937-76F25E75-813F-41D8-A6FC-30F02D31F89D @default.
- Q92804937 P577 Q92804937-C0474C62-9A03-4E57-8059-6FD6255F1149 @default.
- Q92804937 P698 Q92804937-F3CD9788-7087-4BBA-BF28-D03527808D81 @default.
- Q92804937 P921 Q92804937-103238AF-2A51-4BA6-AB54-8609B3BF889B @default.
- Q92804937 P921 Q92804937-C9DFE182-A5BE-45EE-B29B-480D43EA47EB @default.
- Q92804937 P356 J.JPBA.2019.113057 @default.
- Q92804937 P698 31962247 @default.
- Q92804937 P1433 Q15752537 @default.
- Q92804937 P1476 "UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma" @default.
- Q92804937 P2093 "Aurélie Barrail-Tran" @default.
- Q92804937 P2093 "Gaëlle Noé" @default.
- Q92804937 P2093 "Hélène Gouget" @default.
- Q92804937 P2093 "Valérie Furlan" @default.
- Q92804937 P304 "113057" @default.
- Q92804937 P31 Q13442814 @default.
- Q92804937 P356 "10.1016/J.JPBA.2019.113057" @default.
- Q92804937 P478 "181" @default.
- Q92804937 P577 "2019-12-24T00:00:00Z" @default.
- Q92804937 P698 "31962247" @default.
- Q92804937 P921 Q422618 @default.
- Q92804937 P921 Q5138908 @default.